The finding of APE1-AAbs expression in the serum of 38.70% (113/292) of NSCLC patients was statistically significantly higher than that of healthy controls (2.67%, 8/300) (p = 0.000). This evidence concerns the gene APEX1 and non-small cell lung carcinoma.